BCHE Gene - Butyrylcholinesterase

Genetic and functional insights into BCHE, a key enzyme in cholinergic metabolism and drug detoxification.

Gene Information Card

Symbol BCHE
Full Name Butyrylcholinesterase
Gene Type protein-coding
Chromosomal Location 3q26.1
NCBI Gene ID 590 ncbi.nlm.nih.gov/gene/590
Ensembl ID ENSG00000114200
UniProt ID P06276
OMIM ID 177400
HGNC ID 983
Aliases CHE1, E1, pseudocholinesterase, butyrylcholine esterase

Description

The BCHE gene encodes butyrylcholinesterase (BChE), a serine hydrolase that metabolizes choline esters, including acetylcholine and various drugs such as succinylcholine and cocaine. It is synthesized in the liver and secreted into plasma. Genetic variants can lead to prolonged neuromuscular blockade after succinylcholine administration and altered drug metabolism.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Succinylcholine Apnea Reduced or absent BChE activity due to BCHE variants leads to prolonged paralysis after succinylcholine administration. ClinVar, OMIM
Butyrylcholinesterase Deficiency Loss-of-function mutations in BCHE cause decreased plasma cholinesterase activity, resulting in sensitivity to choline ester drugs. OMIM, NCBI
Cocaine Dependence (protective) Certain BCHE variants with increased catalytic efficiency may reduce cocaine toxicity and dependence risk. NCBI, UniProt

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 123.4 High
Plasma N/A High (secreted)
Lung 10.2 Low
Brain 8.5 Low
Kidney 6.1 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 45.6 Hepatocellular carcinoma cell line
A549 12.3 Lung carcinoma cell line
HEK293 3.4 Embryonic kidney cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.293A>G (p.Asp70Gly) Missense Common (allele frequency ~2% in Caucasians) Reduced BChE activity; associated with succinylcholine sensitivity.
c.1615G>A (p.Ala539Thr) Missense Rare Decreased enzyme activity; prolonged apnea risk.
c.424G>A (p.Gly142Arg) Missense Rare Severe loss of function; pseudocholinesterase deficiency.
Mutation functional classification

Loss of Function (LOF)

Most BCHE mutations (e.g., Asp70Gly, Ala539Thr) reduce or abolish enzymatic activity, leading to succinylcholine apnea and drug sensitivity.

Gain of Function (GOF)

Rare variants (e.g., BCHE-K variant) may show altered substrate specificity but not typically gain-of-function.

Dominant Negative (DN)

Not commonly described; BCHE deficiency is usually autosomal recessive.

Gene Ontology (GO)

• GO:0004104 - cholinesterase activity • GO:0005515 - protein binding
• GO:0005615 - extracellular space • GO:0006584 - catecholamine metabolic process
• GO:0016787 - hydrolase activity

Pathways

Acetylcholine degradation (Reactome: R-HSA-2132295)
Cocaine metabolism (Reactome: R-HSA-211981)

Protein Summary

Butyrylcholinesterase (BChE) is a 440-amino-acid glycoprotein that forms tetramers in plasma. It hydrolyzes a broad range of choline esters, including acetylcholine, butyrylcholine, and succinylcholine. BChE also detoxifies cocaine and organophosphate compounds. The enzyme is structurally similar to acetylcholinesterase but has a wider substrate specificity. Genetic polymorphisms affect drug metabolism and toxicity.

Related Products

Product name Cat.No. Species Gene ID
BCHE Knockout HEK293 Cell Line EDJ-KQ12524 Human 590 Details Get a Quote
BCHE Knockout HeLa Cell Line EDJ-KQ18081 Human 590 Details Get a Quote
BCHE Knockout A-549 Cell Line EDJ-KQ41512 Human 590 Details Get a Quote
BCHE Knockout Hep-G2 Cell Line EDJ-KZ117 Human 590 Details Get a Quote
BCHE Knockout HCT 116 Cell Line EDJ-KQ69671 Human 590 Details Get a Quote
BCHE Knockout HAP1 Cell Line EDC08071 Human 590 Details Get a Quote
Displaying Records 1 To 6 Of 6 Records
Contact Us
*
*
*
*
How did you hear about us: